The slower pace of getting gene therapies to patients will most likely require the development of new standards and means of production. (Photo: Getty)

Despite the enormous promise of gene therapies, challenges in producing those therapies may put them out of reach of most American consumers at least in the near future, a new report said.

The report by the PWC Health Research Institute (HRI), outlines a myriad of challenges for gene therapies. Such therapies often are modified for single patients, raising questions of the scalability of the treatments. Rapid production is difficult—but patients are often facing life-threatening diseases and may not have much time. Supply chains and availability are limited: the report notes that only five ZIP codes in the country have health systems that offer all four gene therapies that currently have FDA approval.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

BenefitsPRO Broker Expo 2024Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.